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Abstract
Non-productive antigen receptor genes with frame shifts generated during the assembly of these genes are found in many
mature lymphocytes. Transcripts from these genes have premature termination codons (PTCs) and could encode truncated
proteins if they are not either inactivated or destroyed by nonsense-mediated decay (NMD). In mammalian cells, NMD can
be activated by pathways that rely on the presence of an intron downstream of the PTC; however, NMD can also be
activated by pathways that do not rely on these downstream introns, and pathways independent of NMD can inactivate
PTC-containing transcripts. Here, through the generation and analysis of mice with gene-targeted modifications of the
endogenous T cell receptor beta (Tcrb) locus, we demonstrate that in T cells in vivo, optimal clearance of PTC-containing
Tcrb transcripts depends on the presence of an intron downstream of the PTC.
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Introduction
Lymphocyte antigen receptor chains are composed of N-terminal
variableregions encoded by the first two exons of the antigen receptor
gene and C-terminal constant regions encoded by the remaining
exons [1]. The second exon of all lymphocyte antigen receptor genes
is assembled by the V(D)J recombination reaction, which is initiated
when the RAG endonuclease introduces DNA double strand breaks
at the border of recombining variable (V), diversity (D) and joining (J)
gene segments and their flanking RAG recognition sequences
(recombination signals, RSs) [2]. These DNA double strand breaks
are repaired by the non-homologous end-joining (NHEJ) pathway,
joining the V, D and J gene segments [1]. NHEJ is imprecise and the
random gain and loss of nucleotides that accompanies this joining
process is essential for antigen receptor gene diversification and
adaptive immunity. However,this diversification alsoleads to reading
frame shifts and premature termination codons (PTCs) in two out of
the three reading frames. These out-of-frame antigen receptor alleles
are actively transcribed in lymphocytes, providing a rich source of
PTC-containing transcripts that if not inactivated or destroyed by
nonsense-mediated decay (NMD) could lead to the production of
truncated antigen receptor peptides that could be deleterious to
developing lymphocytes. Consistent with this notion the selective
ablation of Upf2, a central mediator of NMD, in thymocytes leads to
defects in T cell development, which could be due, in part, to the
accumulation of T cell receptor gene transcripts with premature
termination codons [3].
In lower eukaryotes, NMD is activated when PTCs are sensed
based on their distance from the poly(A) tract [4]. In contrast,
mammalian cells can activate NMD through pathways that
recognize termination codons as premature if they lie upstream of
an excised intron, irrespective of their distance from the poly(A)
tract [5,6,7,8]. Activation of this pathway, termed EJC-dependent
NMD, requires that exon junction complexes (EJCs) exist
downstream of ribosomes stalled at PTCs during the first round
of translation [8,9]. EJCs are deposited ,20–24 nt upstream of an
exon-exon border, and in order for a PTC to activate NMD by
EJC-dependent pathways, it must lie at a distance of greater than
50–55 bp upstream of the exon-exon junction [7,9,10,11,12].
Transcripts that have PTCs lying less than 50 bp upstream of
an exon-exon junction or that have PTCs in the final exon are still
able to activate NMD in mammalian cells [5,11,12,13,14].
Activation of NMD by this fail-safe pathway is thought to require
sensing the distance of the PTC from the poly-A tract, as is the
case in lower eukaryotes [15]. Although activation of fail-safe
NMD does not rely on the presence of an intron downstream of
the PTC, it requires the presence of an intron elsewhere in the
gene [11,14,16,17,18]. In addition, mechanisms that, for example,
alter splicing can inactivate PTC-containing transcripts without
leading to their degradation [19,20,21,22,23,24,25,26]. In this
regard, pre-mRNAs with PTCs can accumulate un-spliced, or
incompletely spliced, in the nucleus. Moreover, PTC-containing
transcripts can be alternatively spliced removing the exon with the
PTC, a process termed nonsense-associated altered splicing. How
PTCs are sensed in these incompletely processed transcripts is not
completely understood. Together, these mechanisms prevent
transcripts with PTCs from encoding truncated proteins that
could have detrimental effects.
T cell receptor beta (Tcrb) chain locus transcripts containing
PTCs are readily destroyed by NMD in vivo [27]. Here, we develop
an approach to directly determine the requirement for an intron
downstream of the PTC in efficiently clearing transcripts
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multi-step gene targeting, we generated two minimally modified
versions of the mouse Tcrb locus, Tcrb
A and Tcrb
F, that undergo
normal rearrangement and expression in developing thymocytes.
These two alleles are identical except that Tcrb
A allele PTCs will
have downstream introns whereas Tcrb
F allele PTCs will not. By
comparing the stability of PTC-containing Tcrb
A and Tcrb
F
transcripts in thymocytes, we demonstrate that the normal
clearance of these transcripts relies on the presence of introns
downstream of the PTC.
Results and Discussion
Generation of the Tcrb
A and Tcrb
F alleles
The mouse Tcrb locus spans 0.7 Mb, with 34 Vb gene segments
lying in a 0.4 Mb region upstream of two Db-Jb clusters, each with
a single Db and 6 or 7 Jb gene segments (Fig. 1a) [28]. The second
exon is completed when a Vb gene segment rearranges to a DJb
rearrangement at either of the Db-Jb clusters. Four constant
region exons lie downstream of each Db-Jb cluster (Cb1 and Cb2)
(Fig. 1a). VDJb rearrangements to DJb1 are transcribed with the
four Cb1 exons; likewise, VDJb rearrangements to DJb2 are
transcribed with the four Cb2 exons.
Multi-step gene targeting was used to generate mice with two
modified endogenous Tcrb loci (Tcrb
A and Tcrb
F, Fig. 1b). Initially,
the Db1 gene segment was deleted, limiting rearrangement of Vb
gene segments to the Db2-Jb2 gene segment cluster (Step A,
Fig. 1a, see Jb1
M3 allele in ref. [28]). The Db2, Jb2.1, Jb2.2 and
Jb2.3 gene segments were then replaced with a DJb2.3
rearrangement in its native configuration to generate the Tcrb
A
allele (Step B, Figs. 1a and S1). The Tcrb
F allele is identical to the
Tcrb
A allele except that the four Cb2 exons have been replaced
with a DNA fragment containing a fusion of these exons without
any introns (Step C, Figs. 1a and S2). Importantly, as the Tcrb
A
and Tcrb
F alleles were generated through modest gene targeted
modifications of the wild type endogenous Tcrb locus, the Tcrb
A
and Tcrb
F alleles remain under the same cis-acting regulation
(endogenous Tcrb promoters and enhancers) as the wild type Tcrb
locus.
T cell development in Tcrb
A/A and Tcrb
F/F mice
Efficient assembly and expression of a productive Tcrb chain gene
is required for the normal development of T cells. Several lines of
evidence demonstrate that rearrangement of both the Tcrb
A and
Tcrb
F allelesoccurs with near normalefficiency. First,inlymphnode
Tcrb
A/+ and Tcrb
F/+ T cell hybridomas, complete rearrangements
occurred at a high frequency on both the Tcrb
A and Tcrb
F alleles
(Fig. 2a and Table S1). Moreover, analysis of Tcrb
A/A and Tcrb
F/F T
cell hybridomas revealed that 32% and 35%, respectively, have
complete VDJb rearrangements on both alleles (Fig. 2b and Table
S2). This is close to the maximum 40% expected due to allelic
exclusion [29,30]. Finally, analysis of Tcrb
A/F T cell hybridomas
with single VDJb rearrangements revealed approximately equal
frequencies of VDJb rearrangements on the Tcrb
A and Tcrb
F alleles
(Fig. 2c and Table S3).
Thymocyte development in Tcrb
A/A and Tcrb
F/F mice was
indistinguishable from wild type mice (Fig. 2d and e). In this
regard, wild type (Tcrb
+/+), Tcrb
A/A and Tcrb
F/F mice had similar
numbers of CD4
2:CD8
2 (double negative, DN), CD4
+:CD8
+
(double positive, DP) and CD4
2:CD8
+ or CD4
+:CD8
2 (single
positive, SP) thymocytes (Fig. 2d and e). Flow cytometric analysis
of Tcrb chain expression revealed no significant differences
between Tcrb
A/A, Tcrb
F/F and Tcrb
+/+ thymocytes (data not
shown). Finally, Tcrb
A/A, Tcrb
F/F and Tcrb
+/+ mice have similar
numbers of mature CD4
+ and CD8
+ splenic T cells (Fig. 2f).
Taken together these data demonstrate that the Tcrb
A and Tcrb
F
alleles are efficiently rearranged and expressed and can support
normal T cell development.
Differential stability of PTC-containing Tcrb
A and Tcrb
F
transcripts
Like the wild type Tcrb locus, Tcrb
A PTCs lie in the third of six
exons while Tcrb
F PTCs lie in the third and final exon; thus, Tcrb
A
PTCs have downstream introns whereas Tcrb
F PTCs do not
Figure 1. Tcrb
A and Tcrb
F alleles. (a) Schematic of the mouse Tcrb locus. Vb, Db and Jb gene segments (open boxes), RSs (open triangles), Cb1 and
Cb2 exons (blue boxes), enhancer (Eb and promoters (open circles) and loxP sequences (shaded ovals) are shown. (b) Schematics of the Tcrb
A and
Tcrb
F alleles.
doi:10.1371/journal.pone.0021627.g001
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A and Tcrb
F transcript PTCs lie at the same
distance (0.7 kbp) from the poly(A) tract and have two upstream
introns in the same locations (Fig. 3a). Thus, comparing the
stability of PTC-containing Tcrb
A and Tcrb
F transcripts in Tcrb
A/A
and Tcrb
F/F thymocytes allows us to determine the relative
contribution of mechanisms that rely on introns downstream of
the PTC in mediating degradation of PTC-containing Tcrb
transcripts in vivo.
To this end, Tcrb
A/A and Tcrb
F/F CD25
+ DN thymocytes were
purified by flow cytometric cell sorting and VDJb rearrangements
utilizing five different Vb gene segments were amplified and
sequenced from genomic DNA and cDNAs generated from both
Tcrb pre-mRNAs and mature transcripts. A total of 1592
sequences were analyzed to identify those that are in-frame (no
PTC, PTC
2) and those that are out-of-frame (PTC-containing,
PTC
+) (Table S4). As compared to genomic DNA, the fraction of
PTC
+ Tcrb pre-mRNAs was similar to the fraction of PTC
+ Tcrb
alleles in both Tcrb
A/A and Tcrb
F/F DN thymocytes (Fig. 3b, open
bars and Table S4). As compared to genomic DNA, there is a
twelve-fold reduction in the abundance of PTC
+ mature Tcrb
A
mRNAs (Fig. 3b, red bar and Table S4). In striking contrast, the
abundance of PTC
+ Tcrb
F mRNAs is reduced by only three-fold
(Fig. 3b, red bar and Table S4). Thus, PTC-containing Tcrb
A
mRNAs are eliminated more efficiently than PTC-containing
Tcrb
F mRNAs.
Concluding Remarks
Here, we show that PTC-containing Tcrb
A and Tcrb
F transcripts
have differing abilities to be eliminated in mammalian thymocytes
in vivo. The only difference between the Tcrb
A and Tcrb
F alleles is
the presence of introns downstream of the PTC. Thus, these
findings demonstrate that these downstream introns are mecha-
nistically important components in the efficient elimination of
PTC-containing Tcrb transcripts in vivo, consistent with the notion
that they are required to activate EJC-dependent NMD.
Nevertheless, PTC-containing transcripts templated by the Tcrb
F
allele are reduced three-fold in their abundance. Thus, mecha-
nisms that do not rely on downstream introns are also capable of
eliminating PTC-containing transcripts, although not to levels
achieved when downstream introns are present. As transcripts
templated by the Tcrb
F allele will have two introns it is conceivable
PTC-containing Tcrb
F transcripts can also be inactivated by
nonsense-associated altered splicing or other mechanisms that
alter the splicing of PCT-containing transcripts. Notably, PTCs in
Figure 2. T cell development in Tcrb
A/A and Tcrb
F/F mice. (a) Percent of Tcrb
A (red), Tcrb
F (green) and Tcrb
+ (blue) alleles in the VDJb
configuration in Tcrb
A/+ and Tcrb
F/+ hybridomas. (b) Percent of Tcrb
A/A and Tcrb
F/F hybridomas with one (blue) or two (red) completely rearranged
alleles. (c) Percent of Tcrb
A/F hybridomas with a single complete VDJb rearrangement on the Tcrb
A (blue) or Tcrb
F (red) allele. (d) Flow cytometric
analysis of CD4 and CD8 expression in thymocytes from Tcrb
+/+, Tcrb
A/A and Tcrb
F/F mice. Percentages are indicated. Data are representative of at least
4 mice analyzed for each genotype. (e–f) Number of DN, DP, CD4SP and CD8SP thymocytes (e) and number of CD4
+ and CD8
+ splenic T cells (f) in
Tcrb
+/+ (blue), Tcrb
A/A (red) and Tcrb
F/F (green) mice, depicted as mean +/2 SEM. At least four age-matched mice were analyzed for each genotype.
doi:10.1371/journal.pone.0021627.g002
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ly reside in the last exon, and like Tcrb
F transcripts in thymocytes,
the abundance of PTC-containing immunoglobulin light chain
kappa transcripts is also reduced by about three-fold in developing
B cells [19,31]. We conclude that although PTC-containing Tcrb
transcripts can be eliminated by several mechanisms in developing
lymphocytes in vivo, maximal elimination of these transcripts
depends on mechanisms that rely on the presence of introns
downstream of the PTC.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocol was
approved by the Washington University Animal Studies Committee
(#20070189).
Generation of Tcrb
A/A and Tcrb
F/F mice
The 59 homology arm of pLNTK-DJ (Fig. S1) contains a
Db2Jb2.3 rearrangement amplified with 59HDJ and 39Jb2-3 and
the Jb2.4-Jb2.7 gene segments amplified with 59Jb2.4US and
39Jb2.7DS (oligonucleotide sequences are listed in Table S5). The
Jb2.3 gene segment has a single G to C change to eliminate a PTC
generated using the 59Jb2.3, Jb2.3M1, Jb2.3M2 and 39Jb2.3X,
oligonucleotides. The 39 homology arm is a 3.2 kbp ClaI/SpeI
fragment downstream of Jb2.7. The 59 homology arm of pLNTK-
Cb2F (Fig. S2) is a 2 kbp ClaI/PstI Tcrb fragment. The 39 homology
arm was generated by amplifying the constant region of a Tcrb cDNA
with oligonucleotides A through F, 59Cb2-39Ha n d3 9Cb2-39Ha s
shown in figure S2. Deletion of the Db1 gene segment is described
elsewhere [32]. Embryonic stem cells (ES) were transfected, selected
and injected into C57BL/6 blastocysts as previously described [32].
Intercrossing of Tcrb
A/+ and Tcrb
F/+ mice led to the expected
Mendelian ratios of Tcrb
A/A and Tcrb
F/F mice, respectively.
Southern blotting
Southern blot analysis of ES cells targeted with pLNTK-DJ was
performed on SacI-digested genomic DNA with probe A as
previously described [33]. For ES cells targeted with pLNTK-
Cb2F, PstI-digested genomic DNA was probed with a 400 bp
HincII/BamHI genomic fragment 39 of the 39 homology arm, and
SacI-digested genomic DNA probed with probe A.
Hybridomas
Hybridomas were generated and Tcrb gene rearrangements
analyzed as previously described [23].
Flow cytometric analyses and cell purification
Flow cytometric analyses were performed on a FACSCalibur
(BD Biosciences) using FITC-conjugated anti-CD25, PE-Cy5-
conjugated anti-CD4 and FITC-conjugated anti-CD8. CD25
+
DN thymocytes were purified from 4–5 mice for each genotype by
flow cytometric cell sorting (FACSVantage BD Biosciences).
Sequence analyses
Genomic DNA and RNA were isolated as previously described
from CD25
+ DN thymocytes purified by flow cytometric cell
sorting [33,34]. The SuperScriptII Reverse Transcriptase kit
(Invitrogen) was used to synthesize cDNA using oligo-dT or the
intronic 39Jb2-11 oligonucleotide for mature mRNA or pre-
mRNA, respectively. VDJb rearrangements were amplified from
DNA using Vb2, Vb6, Vb8.1, Vb14 or Vb16 and 39Jb2-6. PCR
conditions were 200 ng genomic DNA in 50 uL with 1 mM
MgCl2, 100 mM dNTPs and 10 picomoles of each oligonucleotide
for 17 cycles of 92uC (1:00), 60uC (1:30), and 72uC (1:30), followed
by secondary amplification for 30 cycles using 39Jb2-3 and the
same Vb oligonucleotide. cDNA was amplified as above, except
using Cb2-1 and Cb2-2 oligonucleotides in the primary and
secondary reactions, respectively. The significance of the fold
decrease of pre-mRNA or mRNA relative to DNA was calculated
using a binomial test. The p-value for fold decrease of mRNA for
Tcrb
A versus Tcrb
F was calculated using a Monte Carlo simulation
(script available on request).
Supporting Information
Figure S1 Targeting strategy for generating the Tcrb
A
allele. Generation of the Tcrb
A allele. Shown is a schematic of
Figure 3. PTC-containing Tcrb
F transcripts show resistance to NMD. (a) Tcrb
A and Tcrb
F alleles with completely assembled second exons
(VDJb), with four Cb2 exons (blue rectangles 3, 4 5 and 6,Tcrb
A) or the fusion of these exons (blue rectangle 3, Tcrb
F). The positions of the two
potential PTCs (red octagons) and the normal termination codon (TC, open octagon) are shown. Pre-mRNAs with exons (green bars) and introns
(connecting black lines) are shown, as are completely processed PTC-containing Tcrb
A and Tcrb
F transcripts (green bars) with exon junctions (EJ,
purple dots). (b) Fold reduction (relative to PTC-containing alleles) in PTC-containing Tcrb pre-mRNA (open bars) and completely processed mRNA
(red bars) in Tcrb
A/A and Tcrb
F/F DN thymocytes. P-values were calculated by a binomial test for pre-mRNA versus mRNA, and by Monte Carlo
simulation for Tcrb
A/A versus Tcrb
F/F.
doi:10.1371/journal.pone.0021627.g003
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deleted (top, Jb1
M3 in ref. [28]). The Db and Jb gene segments are
shown as open rectangles (except for Jb2.3, shown as a shaded
rectangle) and the RSs as open triangles. The Cb1 and Cb2 exons
(blue rectangles) are also shown, as is the pLNTK-DJ targeting
vector used to generate the Tcrb
A+Neo allele, which has a targeted
replacement of the Db2, Jb2.1, Jb2.2 and Jb2.3 gene segments
with a Db2Jb2.3 rearrangement and the loxP-flanked neomycin
resistance gene (Neo
R). The Tcrb
A allele generated after Cre-
mediated deletion of the neomycin resistance gene, leaving a single
loxP site (filled oval), is shown. The relative positions of the
different restriction sites are shown, as is probe A, which was used
for Southern blot analysis of the different targeted alleles. Also
shown is a Southern blot of genomic DNA from targeted ES cell
lines digested with SacI and hybridized to probe A. The molecular
weight markers and relative positions of the bands generated by
the different Tcrb alleles are indicated.
(TIF)
Figure S2 Targeting strategy for generating the Tcrb
F
allele. a) GenerationoftheCb2fusion.Shownareschematicsofthe
four Cb2 exons (labeled 1 through 4) in genomic DNA and in cDNA
generated from completelyprocessed mRNA, and oligonucleotides A
through F (labeled arrows).b) Generation of the Tcrb
Fallele. Shown is
a schematic of the Cb2 region of the Tcrb
A allele (top) and the
pLNTK-Cb2F targeting vector used to generate the Tcrb
F+Neo allele,
which has a targeted replacement of the four Cb2 exons with a DNA
fragment containing a fusion of these exons and the loxP-flanked
neomycin resistance gene. Also shown is the Tcrb
F allele generated
after Cre-mediated deletion of the neomycin resistance gene, leaving
as i n g l eloxP site. The relative positions of the different restriction sites
are shown, as are probes A and B, which were used for Southern blot
analyses. Southern blots of genomic DNA from targeted ES cell lines
that were digested with PstI and hybridized to probe B, or digested
with SacI and hybridized to probe A are shown. The molecular
weight markers and relative position of the bands generated by the
different Tcrb alleles are indicated.
(TIF)
Table S1 Number of Tcrb
A, Tcrb
F and Tcrb
+ alleles in the VDJb
configuration in the Tcrb
F/+ and Tcrb
A/+ T cell hybridomas
analyzed. The total number (n) of hybridomas analyzed is
indicated.
(TIF)
Table S2 Number of Tcrb
A/A and Tcrb
F/F T cell hybridomas
with Tcrb alleles in the VDJb/DJb and VDJb/VDJb configuration.
(TIF)
Table S3 Number of Tcrb
A/F T cell hybridomas with Tcrb alleles
in the VDJb
A/DJb
F and DJb
A/VDJb
F configuration.
(TIF)
Table S4 Total number of sequences (n) and the number with
(PTC
+) or without (PTC
2) PTCs from genomic DNA, pre-mRNA
and mRNA from Tcrb
A/A and Tcrb
F/F DN thymocytes.
(TIF)
Table S5 Oligonucleotide sequences.
(TIF)
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